false
0001582982
0001582982
2026-03-24
2026-03-24
0001582982
CCLD:CommonStockParValue0.001PerShareMember
2026-03-24
2026-03-24
0001582982
CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember
2026-03-24
2026-03-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 24, 2026

CareCloud,
Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-36529 |
|
22-3832302 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
7
Clyde Road, Somerset, New Jersey 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
CCLD |
|
Nasdaq
Global Market |
| 8.75%
Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share |
|
CCLDO |
|
Nasdaq
Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.05 Material Cybersecurity Incidents.
On
March 16, 2026, CareCloud, Inc. (the “Company”) experienced a temporary network disruption in its CareCloud Health
division that partially impacted the functionality and data access to 1 of its 6 electronic health record environments for
approximately 8 hours until the Company fully restored all functionality and data access during that evening. Upon discovery of this
incident, the Company promptly reported the matter to its cybersecurity carrier and engaged a leading cyber response advisory team
which is part of a Big Four accounting firm to perform external cybersecurity work and to assist with securing the environment, as
well as to conduct a comprehensive IT forensic investigation to determine the nature and scope of this incident.
The
Company further believes that the incident was contained to the CareCloud Health environment and did not affect the Company’s other
platforms, divisions, systems, data or environments. The incident was contained on the day it was discovered. The Company believes that
it has sufficient cybersecurity insurance coverage for any potential losses. The Company further believes that the incident was caused
by an unauthorized third party who temporarily had access to the system. The Company has reported the matter to the appropriate law enforcement
authorities.
The
Company is continuing to investigate the nature and scope of the incident. The affected environment stores patient information, and the
Company continues to assess whether, and the extent to which, patient information or other data was accessed or exfiltrated, and the
categories and volume of any such data.
All
affected systems have been fully restored, and the Company believes that the threat actor no longer has any access to the same. As part
of its remediation efforts, the Company is working with its outside cybersecurity experts to further reinforce its information technology
systems and to prevent future unauthorized access.
As
of the date of this Current Report on Form 8-K, the incident has not had a material impact on the Company’s operations. On March
24, 2026, the Company nevertheless determined that the incident is material in light of the sensitivity of the potentially affected information
and the potential consequences of the incident, including remediation and response costs, legal, regulatory and notification-related
matters, and possible effects on patients, customers, counterparties, reputation and operations. The Company believes that the incident
is not reasonably likely to have a material impact on the Company’s financial condition or results of operations but has not yet
determined the full impact of the incident. To the extent any information required by Item 1.05(a) of Form 8-K was not determined or
was unavailable at the time of this filing, the Company will amend this Current Report on Form 8-K as such information is determined
or becomes available.
Cautionary
Statement Regarding Forward-Looking Statements
This
Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws, including statements
regarding the scope of the incident, whether and to what extent patient information or other data was accessed or exfiltrated, the categories
and volume of data affected, the effectiveness of the Company’s containment and remediation efforts, the Company’s assessment
of notification obligations, and the actual and reasonably likely impact of the incident on the Company’s business, operations,
financial condition and results of operations. These statements are based on current information, estimates and assumptions and are subject
to risks and uncertainties. Actual results may differ materially from those expressed or implied by these forward-looking statements.
Except as required by law, the Company undertakes no obligation to update these statements.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
|
CareCloud,
Inc. |
| |
|
|
|
| Date: |
March 27, 2026 |
By: |
/s/
Norman Roth |
| |
|
|
Norman
Roth |
| |
|
|
Interim
Chief Financial Officer and Corporate Controller |